Pulse nav.journalClub Trends Entdecken Fragen Forschende

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Datenschutz

Start Entdecken nav.journalClub Trends

⌘+K

Errata for Biological and Pharmaceutical Bulletin | Synapse

March 1, 2024Open Access

Errata for Biological and Pharmaceutical Bulletin

Key Points

Key points are not available for this paper at this time.

Abstract

Left ↑7 100 ng/mL FGF2, 30 ng/mL epidermal growth factor (EGF) 30

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Cite This Study

A Fri, study studied this question.

synapsesocial.com/papers/68e7681cb6db6435876dd208 https://doi.org/https://doi.org/10.1248/bpb.b24-e4702b

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TARGET ONCOGENIC RECEPTORS IN TUMOURS, FROM ITS INITIAL CLINICAL BREAKTHROUGHS TO CURRENT CLINICAL STANDARD THERAPY2024 · 1 citations
2Understanding the Aggregation Mechanism of and Developing Stabilization Strategies for Recombinant Fibroblast Growth Factor 22026
3Purification Method Optimization of Recombinant Basic Fibroblast Growth Factor rhFGF-2 Expressed in Methylotrophic Yeast Pichia pastoris2025
4Regulation of vascular angiotensin II receptors by EGF1997 · 23 citations
5Fibroblast Growth Factor-2 and Enamel Matrix Derivative Enhance Proliferation, Migration, and Wound Healing in Gingival Epithelial and Fibroblast Cells2026